The Prognostic Analysis of Different Metastatic Patterns Extensive-Stage Small-Cell Lung Cancer Patients: A Large Population-Based Study

References

• Rudin CM , IsmailaN, HannCLet al. Treatment of small-cell lung cancer: American Society of Clinical Oncology endorsement of the American College of Chest Physicians guideline. J. Clin. Oncol.33(34), 4106–4111 (2015).
   PubMed Web of Science ®Google Scholar
• Tarver T . American Cancer Society Cancer Facts & Figures 2014. J. Consumer Health Internet16(3), 366–367 (2012).
   Google Scholar
• Slotman BJ , TinterenHV, PraagJOet al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a Phase III randomised controlled trial. Lancet385(9962), 36–42 (2015).
   PubMed Web of Science ®Google Scholar
• Gore EM , HuC, SunAYet al. Randomized Phase II study comparing prophylactic cranial irradiation alone to prophylactic cranial irradiation and consolidative extra-cranial irradiation for extensive disease small cell lung cancer (ED-SCLC), NRG oncology RTOG 0937. J. Thorac. Oncol.12(10), 1561 (2017).
   PubMed Web of Science ®Google Scholar
• Jeremic B , ShibamotoY, NikolicNet al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J. Clin. Oncol.17(7), 2092 (1999).
   PubMed Web of Science ®Google Scholar
• Takahashi T , YamanakaT, SetoTet al. Prophylactic cranial irradiation versus observation in patients with extensive-disease small cell lung cancer: a multicentre, randomized, open-label, Phase III trial. Lancet Oncol.18(5), 663–671 (2017).
   PubMed Web of Science ®Google Scholar
• Byers LA , RudinCM. Small cell lung cancer: where do we go from here?Cancer121(5), 664–672 (2015).
   PubMed Web of Science ®Google Scholar
• Tartarone A , GiordanoP, LeroseR, RodriquenzMG, ConcaR, AietaM. Progress and challenges in the treatment of small cell lung cancer. Med. Oncol.34(6), 110 (2017).
   PubMed Web of Science ®Google Scholar
• Lally BE , UrbanicJJ, BlackstockAW, MillerAA, PerryMC. Small cell lung cancer: have we made any progress over the last 25 years?Oncologist12(9), 1096 (2007).
   PubMed Web of Science ®Google Scholar
• Nakazawa K , KurishimaK, TamuraTet al. Specific organ metastases and survival in small cell lung cancer. Oncol. Lett.4(4), 617 (2012).
   PubMed Web of Science ®Google Scholar
• Tas F , AydinerA, CamlicaH, SaipP, EralpY. Factors influencing the distribution of metastases and survival in extensive disease small cell lung cancer. Acta Oncol.38(8), 1011 (1999).
   PubMed Web of Science ®Google Scholar
• Surveillance: Epidemiology: and End Results (SEER) Program. SEER*Stat Database: Incidence - SEER 18 Regs Research Data + Hurricane Katrina Impacted Louisiana Cases: Nov 2016 Sub (1973–2014 varying) - Linked To County Attributes - Total U.S.: 1969–2015 Counties: National Cancer Institute: DCCPS: Surveillance Research Program: released April 2017: based on the November 2016 submission. www.seer.cancer.gov.
   Google Scholar
• Chi H , ZhangC, WangH, WangZ. The appropriate number of ELNs for lymph node negative breast cancer patients underwent MRM, a population-based study. Oncotarget8(39), 65668–65676 (2017).
   PubMedGoogle Scholar
• Demedts IK , VermaelenKY, Van MeerbeeckJP. Treatment of extensive-stage small cell lung carcinoma: current status and future prospects. Eur. Respir. J.35(1), 202–215 (2010).
   PubMed Web of Science ®Google Scholar
• Zhu YJ , ZhangHB, LiuYHet al. Meta-analysis of the role of bevacizumab in extensive stage small cell lung cancer. Oncol Lett14(1), 655–664 (2017).
   PubMed Web of Science ®Google Scholar
• Riihimaki M , HemminkiA, FallahMet al. Metastatic sites and survival in lung cancer. Lung Cancer86(1), 78–84 (2014).
   PubMed Web of Science ®Google Scholar
• Ren Y , DaiC, ZhengHet al. Prognostic effect of liver metastasis in lung cancer patients with distant metastasis. Oncotarget7(33), 53245 (2016).
   PubMedGoogle Scholar
• Kagohashi K , SatohH, IshikawaH, OhtsukaM, SekizawaK. Liver metastasis at the time of initial diagnosis of lung cancer. Med. Oncol.20(1), 25–28 (2003).
   PubMed Web of Science ®Google Scholar
• Kang EJ , LeeSY, KimHJet al. Prognostic factors and skeletal-related events in patients with small cell lung cancer with bone metastases at the time of diagnosis. Oncology90(2), 103–111 (2016).
   PubMed Web of Science ®Google Scholar
• Reveiz L , RuedaJR, CardonaAF. Chemotherapy for brain metastases from small cell lung cancer. Cochrane Database Syst. Rev.6(6), CD007464 (2012).
   Google Scholar
• Lekic M , KovacV, TrillerN, KnezL, SadikovA, CuferT. Outcome of small cell lung cancer (SCLC) patients with brain metastases in a routine clinical setting. Radiol. Oncol.46(1), 54–59 (2012).
   PubMed Web of Science ®Google Scholar
• Ham B , WangN, D’costaZet al. TNF Receptor-2 facilitates an immunosuppressive microenvironment in the liver to promote the colonization and growth of hepatic metastases. Cancer Res.75(24), 5235–5247 (2015).
   PubMed Web of Science ®Google Scholar
• Satoh H . Application of conditional probability analysis to distant metastases from lung cancer. Oncol. Lett.3(3), 629–634 (2011).
   PubMed Web of Science ®Google Scholar
• Wu KL , TsaiMJ, YangCJet al. Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib. Lung Cancer88(2), 187–194 (2015).
   PubMed Web of Science ®Google Scholar
• Postmus PE , Haaxma-ReicheH, SmitEFet al. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy – a Phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group. J. Clin. Oncol.18(19), 3400–3408 (2000).
   PubMed Web of Science ®Google Scholar
• Sahmoun AE , CaseLD, ChavourS, KareemS, SchwartzGG. Hypertension and risk of brain metastasis from small cell lung cancer: a retrospective follow-up study. Anticancer Res.24(5B), 3115–3120 (2004).
   PubMed Web of Science ®Google Scholar
• Albain KS , CrowleyJJ, LivingstonRB. Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience. Am. J. Med.99(6), 1425 (1991).
   Google Scholar
• Tamura M , UeokaH, KiuraKet al. Prognostic factors of small-cell lung cancer in Okayama Lung Cancer Study Group Trials. Acta Medica Okayama52(2), 105 (1998).
   PubMed Web of Science ®Google Scholar
• Sugiura H , YamadaK, SugiuraT, HidaT, MitsudomiT. Predictors of survival in patients with bone metastasis of lung cancer. Clin. Orthop. Relat. Res.466(3), 729–736 (2008).
   PubMed Web of Science ®Google Scholar
• Charpidou A , TsagouliS, GkiozosIet al. Bone metastases in patients with small cell lung carcinoma: rate of development: early versus late onset: modality of treatment: and their impact on survival. A single-institution retrospective cohort study. Clin. Exp. Metastasis33(5), 453–460 (2016).
   PubMed Web of Science ®Google Scholar
• Kakiuchi S , DaigoY, TsunodaT, YanoS, SoneS, NakamuraY. Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice11 “Research for the Future” program grant of the Japan Society for the Promotion of Science (no. 00L01402) to Y.N. Mol. Cancer Res.1(7), 485–499 (2003).
   PubMed Web of Science ®Google Scholar
• Miki T , YanoS, HanibuchiM, KanematsuT, MugurumaH, SoneS. Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis: but not visceral metastasis: by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice. Int. J. Cancer108(4), 511–515 (2004).
   PubMed Web of Science ®Google Scholar
• Yeo SG , KimMJ. Stereotactic body radiation therapy for the treatment of a post-chemotherapy remnant lung mass in extensive-stage small-cell lung cancer: a case report. Exp. Ther. Med.12(2), 1185–1188 (2016).
   PubMed Web of Science ®Google Scholar